SeqOne Genomics

About:

SeqOne is a next generation genomic analysis for next generation healthcare.

Website: https://seqone.com

Twitter/X: seqonegenomics

Top Investors: Bpifrance, Elaia, Omnes Capital, Mérieux Equity Partners, IRDI SORIDEC Gestion

Description:

Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.

Total Funding Amount:

23M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Montpellier, Languedoc-Roussillon, France

Founded Date:

2017-05-01

Contact Email:

contact(AT)seqone.com

Founders:

Guillaume Buwalda, Jean-Marc Holder, Nicolas Philippe

Number of Employees:

51-100

Last Funding Date:

2022-01-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai